Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Goodwill & Intangibles (2020 - 2025)

Beauty Health (SKIN) has disclosed Goodwill & Intangibles for 6 consecutive years, with $45.6 million as the latest value for Q1 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 63.59% to $45.6 million in Q1 2025 year-over-year; TTM through Mar 2025 was $45.6 million, a 63.59% decrease, with the full-year FY2024 number at $171.0 million, up 175.28% from a year prior.
  • Goodwill & Intangibles was $45.6 million for Q1 2025 at Beauty Health, down from $171.0 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $182.2 million in Q3 2021 to a low of $5.0 million in Q1 2023.
  • A 5-year average of $116.7 million and a median of $125.4 million in 2023 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: crashed 63.67% in 2023, then skyrocketed 2407.3% in 2024.
  • Beauty Health's Goodwill & Intangibles stood at $179.7 million in 2021, then dropped by 4.86% to $171.0 million in 2022, then crashed by 63.67% to $62.1 million in 2023, then soared by 175.28% to $171.0 million in 2024, then crashed by 73.31% to $45.6 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Goodwill & Intangibles are $45.6 million (Q1 2025), $171.0 million (Q4 2024), and $179.0 million (Q2 2024).